Naturally occurring phytochemicals for the prevention of Alzheimer's disease

Journal of Neurochemistry

Volumn 112, Issue 6, 2010, Pages 1415-1430

  Kim, Jiyoung ^a,b   Lee, Hyong Joo ^a   Lee, Ki Won ^b  

^a Seoul National University   (South Korea)

^b Konkuk University   (South Korea)

Author keywords

( ) epigallocatechin 3 gallate; Alzheimer's disease; Amyloid ; Curcumin; Phytochemicals; Resveratrol

Indexed keywords

ACUTE PHASE PROTEIN; ALPHA TOCOPHEROL; AMYLOID BETA PROTEIN; ASCORBIC ACID; CATECHIN; CHEMOKINE; COMPLEMENT; CURCUMIN; CYCLOOXYGENASE 2; CYTOKINE; DONEPEZIL; EPIGALLOCATECHIN GALLATE; FREE RADICAL; GALANTAMINE; INDUCIBLE NITRIC OXIDE SYNTHASE; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2; MEMANTINE; NITRIC OXIDE; PLANT MEDICINAL PRODUCT; POLYPHENOL; PROSTAGLANDIN; PROTEIN S 100; RESVERATROL; RIVASTIGMINE; TACRINE;

ABDOMINAL PAIN; ALZHEIMER DISEASE; ANTIINFLAMMATORY ACTIVITY; ANTIOXIDANT ACTIVITY; ASTHENIA; CELLULAR STRESS RESPONSE; CLINICAL TRIAL; COGNITIVE DEFECT; CONFUSION; DIARRHEA; DIZZINESS; DRUG INDUCED HEADACHE; DRUG MECHANISM; DRUG RESEARCH; DRUG TOLERABILITY; ENCEPHALITIS; FATIGUE; HALLUCINATION; HUMAN; INSOMNIA; LIVER TOXICITY; MEMORY DISORDER; NAUSEA; NEUROPATHOLOGY; NIGHTMARE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS INHIBITION; REVIEW; SENILE PLAQUE; SIDE EFFECT; SOMNOLENCE; SPATIAL MEMORY; STOMACH IRRITATION; TEA; URINE INCONTINENCE; VOMITING; WEIGHT REDUCTION;

ALZHEIMER DISEASE; AMYLOID BETA-PROTEIN; ANIMALS; ANTIOXIDANTS; CATECHIN; COGNITION DISORDERS; CURCUMIN; DIETARY SUPPLEMENTS; HUMANS; OXIDATIVE STRESS; PHYTOTHERAPY; PLANT EXTRACTS; STILBENES;

EID: 77349084360     PISSN: 00223042     EISSN: 14714159     Source Type: Journal    
DOI: 10.1111/j.1471-4159.2009.06562.x     Document Type: Review

References (176)

1. Ahmed S., Rahman A., Hasnain A., Lalonde M., Goldberg V. M. Haqqi T. M. (2002) Green tea polyphenol epigallocatechin-3-gallate inhibits the IL-1 beta-induced activity and expression of cyclooxygenase-2 and nitric oxide synthase-2 in human chondrocytes. Free Radic. Biol. Med. 33, 1097 1105.
2. Aisen P. S. (2000) Anti-inflammatory therapy for Alzheimer's disease: implications of the prednisone trial. Acta Neurol. Scand. Suppl. 176, 85 89.
3. Aisen P. S., Schmeidler J. Pasinetti G. M. (2002) Randomized pilot study of nimesulide treatment in Alzheimer's disease. Neurology 58, 1050 1054.
4. Aisen P. S., Schafer K. A., Grundman M., Pfeiffer E., Sano M., Davis K. L., Farlow M. R., Jin S., Thomas R. G. Thal L. J. (2003) Effects of rofecoxib or naproxen vs placebo on Alzheimer disease progression: a randomized controlled trial. JAMA 289, 2819 2826.
5. Akiyama H., Barger S., Barnum S. et al. (2000) Inflammation and Alzheimer's disease. Neurobiol. Aging 21, 383 421.
6. Ates O., Cayli S., Altinoz E., Gurses I., Yucel N., Sener M., Kocak A. Yologlu S. (2007) Neuroprotection by resveratrol against traumatic brain injury in rats. Mol. Cell. Biochem. 294, 137 144.
7. Barber S. C., Higginbottom A., Mead R. J., Barber S. Shaw P. J. (2009) An in vitro screening cascade to identify neuroprotective antioxidants in ALS. Free Radic. Biol. Med. 46, 1127 1138.
8. Bard F., Cannon C., Barbour R. et al. (2000) Peripherally administered antibodies against amyloid beta-peptide enter the central nervous system and reduce pathology in a mouse model of Alzheimer disease. Nat. Med. 6, 916 919.
9. Bastianetto S., Yao Z. X., Papadopoulos V. Quirion R. (2006) Neuroprotective effects of green and black teas and their catechin gallate esters against beta-amyloid-induced toxicity. Eur. J. Neurosci. 23, 55 64.
10. Baum L. Ng A. (2004) Curcumin interaction with copper and iron suggests one possible mechanism of action in Alzheimer's disease animal models. J. Alzheimers Dis. 6, 367 377.
11. Behl C., Davis J. B., Lesley R. Schubert D. (1994) Hydrogen peroxide mediates amyloid beta protein toxicity. Cell 77, 817 827.
12. Bengmark S. (2006) Curcumin, an atoxic antioxidant and natural NFkappaB, cyclooxygenase-2, lipooxygenase, and inducible nitric oxide synthase inhibitor: a shield against acute and chronic diseases. J. Parenter. Enteral Nutr. 30, 45 51.
13. Bi X. L., Yang J. Y., Dong Y. X., Wang J. M., Cui Y. H., Ikeshima T., Zhao Y. Q. Wu C. F. (2005) Resveratrol inhibits nitric oxide and TNF-alpha production by lipopolysaccharide-activated microglia. Int. Immunopharmacol. 5, 185 193.
14. Blasko I., Marx F., Steiner E., Hartmann T. Grubeck-Loebenstein B. (1999) TNFalpha plus IFNgamma induce the production of Alzheimer beta-amyloid peptides and decrease the secretion of APPs. FASEB J. 13, 63 68.
15. Boehm K., Borrelli F., Ernst E., Habacher G., Hung S. K., Milazzo S. Horneber M. (2009) Green tea (Camellia sinensis) for the prevention of cancer. Cochrane Database Syst. Rev. 8, CD005004.
16. Bournival J., Quessy P. Martinoli M. G. (2009) Protective effects of resveratrol and quercetin against MPP(+)-induced oxidative stress act by modulating markers of apoptotic death in dopaminergic neurons. Cell. Mol. Neurobiol. 29, 1169 1180.
17. Breitner J. C., Gau B. A., Welsh K. A., Plassman B. L., McDonald W. M., Helms M. J. Anthony J. C. (1994) Inverse association of anti-inflammatory treatments and Alzheimer's disease: initial results of a co-twin control study. Neurology 44, 227 232.
18. Calabrese E. J., Bachmann K. A., Bailer A. J. et al. (2007a) Biological stress response terminology: Integrating the concepts of adaptive response and preconditioning stress within a hormetic dose-response framework. Toxicol. Appl. Pharmacol. 222, 122 128.
19. Calabrese V., Guagliano E., Sapienza M., Panebianco M., Calafato S., Puleo E., Pennisi G., Mancuso C., Butterfield D. A. Stella A. G. (2007b) Redox regulation of cellular stress response in aging and neurodegenerative disorders: role of vitagenes. Neurochem. Res. 32, 757 773.
20. Calabrese V., Cornelius C., Mancuso C. et al. (2008) Cellular stress response: a novel target for chemoprevention and nutritional neuroprotection in aging, neurodegenerative disorders and longevity. Neurochem. Res. 33, 2444 2471.
21. Calabrese V., Cornelius C., Dinkova-Kostova A. T. Calabrese E. J. (2009a) Vitagenes, cellular stress response, and acetylcarnitine: relevance to hormesis. BioFactors (Oxford, England) 35, 146 160.
22. Calabrese V., Cornelius C., Mancuso C., Barone E., Calafato S., Bates T., Rizzarelli E. Kostova A. T. (2009b) Vitagenes, dietary antioxidants and neuroprotection in neurodegenerative diseases. Front. Biosci. 14, 376 397.
23. Candelario-Jalil E., de Oliveira A. C., Graf S., Bhatia H. S., Hull M., Munoz E. Fiebich B. L. (2007) Resveratrol potently reduces prostaglandin E2 production and free radical formation in lipopolysaccharide-activated primary rat microglia. J. Neuroinflammation 4, 25.
24. Cao Z. Li Y. (2004) Potent induction of cellular antioxidants and phase 2 enzymes by resveratrol in cardiomyocytes: protection against oxidative and electrophilic injury. Eur. J. Pharmacol. 489, 39 48.
25. Chen C., Yu R., Owuor E. D. Kong A. N. (2000) Activation of antioxidant-response element (ARE), mitogen-activated protein kinases (MAPKs) and caspases by major green tea polyphenol components during cell survival and death. Arch. Pharm. Res. 23, 605 612.
26. Chen J., Tang X. Q., Zhi J. L., Cui Y., Yu H. M., Tang E. H., Sun S. N., Feng J. Q. Chen P. X. (2006) Curcumin protects PC12 cells against 1-methyl-4-phenylpyridinium ion-induced apoptosis by bcl-2-mitochondria-ROS-iNOS pathway. Apoptosis 11, 943 953.
27. Choi Y. T., Jung C. H., Lee S. R., Bae J. H., Baek W. K., Suh M. H., Park J., Park C. W. Suh S. I. (2001) The green tea polyphenol (-)-epigallocatechin gallate attenuates beta-amyloid-induced neurotoxicity in cultured hippocampal neurons. Life Sci. 70, 603 614.
28. Choi J. Y., Park C. S., Kim D. J., Cho M. H., Jin B. K., Pie J. E. Chung W. G. (2002) Prevention of nitric oxide-mediated 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced Parkinson's disease in mice by tea phenolic epigallocatechin 3-gallate. Neurotoxicology 23, 367 374.
29. Combs C. K., Karlo J. C., Kao S. C. Landreth G. E. (2001) Beta-amyloid stimulation of microglia and monocytes results in TNFalpha-dependent expression of inducible nitric oxide synthase and neuronal apoptosis. J. Neurosci. 21, 1179 1188.
30. Dance-Barnes S. T., Kock N. D., Moore J. E., Lin E. Y., Mosley L. J., D'Agostino R. B., Jr., McCoy T. P., Townsend A. J. Miller M. S. (2009) Lung tumor promotion by curcumin. Carcinogenesis 30, 1016 1023.
31. Della-Morte D., Dave K. R., Defazio R. A., Bao Y. C., Raval A. P. Perez-Pinzon M. A. (2009) Resveratrol pretreatment protects rat brain from cerebral ischemic damage via a sirtuin 1 - uncoupling protein 2 pathway. Neuroscience 159, 993 1002.
32. DeMattos R. B., Bales K. R., Cummins D. J., Dodart J. C., Paul S. M. Holtzman D. M. (2001) Peripheral anti-A beta antibody alters CNS and plasma A beta clearance and decreases brain A beta burden in a mouse model of Alzheimer's disease. Proc. Natl Acad. Sci. USA 98, 8850 8855.
33. Dickey C. A., Kamal A., Lundgren K. et al. (2007) The high-affinity HSP90-CHIP complex recognizes and selectively degrades phosphorylated tau client proteins. J. Clin. Invest. 117, 648 658.
34. Dodart J. C., Bales K. R., Gannon K. S. et al. (2002) Immunization reverses memory deficits without reducing brain Abeta burden in Alzheimer's disease model. Nat. Neurosci. 5, 452 457.
35. Duthie S. J. (2007) Berry phytochemicals, genomic stability and cancer: evidence for chemoprotection at several stages in the carcinogenic process. Mol. Nutr. Food Res. 51, 665 674.
36. Ehrnhoefer D. E., Duennwald M., Markovic P. et al. (2006) Green tea (-)-epigallocatechin-gallate modulates early events in huntingtin misfolding and reduces toxicity in Huntington's disease models. Hum. Mol. Genet. 15, 2743 2751.
37. Ehrnhoefer D. E., Bieschke J., Boeddrich A., Herbst M., Masino L., Lurz R., Engemann S., Pastore A. Wanker E. E. (2008) EGCG redirects amyloidogenic polypeptides into unstructured, off-pathway oligomers. Nat. Struct. Mol. Biol. 15, 558 566.
38. Farombi E. O., Shrotriya S., Na H. K., Kim S. H. Surh Y. J. (2008) Curcumin attenuates dimethylnitrosamine-induced liver injury in rats through Nrf2-mediated induction of heme oxygenase-1. Food Chem. Toxicol. 46, 1279 1287.
39. Fassbender K., Walter S., Kuhl S. et al. (2004) The LPS receptor (CD14) links innate immunity with Alzheimer's disease. FASEB J. 18, 203 205.
40. Ferrer I., Boada Rovira M., Sanchez Guerra M. L., Rey M. J. Costa-Jussa F. (2004) Neuropathology and pathogenesis of encephalitis following amyloid-beta immunization in Alzheimer's disease. Brain Pathol. 14, 11 20.
41. Fonseca M. I., Zhou J., Botto M. Tenner A. J. (2004) Absence of C1q leads to less neuropathology in transgenic mouse models of Alzheimer's disease. J. Neurosci. 24, 6457 6465.
42. Francis P. T., Palmer A. M., Snape M. Wilcock G. K. (1999) The cholinergic hypothesis of Alzheimer's disease: a review of progress. J. Neurol. Neurosurg. Psychiatry 66, 137 147.
43. Frautschy S. A., Hu W., Kim P., Miller S. A., Chu T., Harris-White M. E. Cole G. M. (2001) Phenolic anti-inflammatory antioxidant reversal of Abeta-induced cognitive deficits and neuropathology. Neurobiol. Aging 22, 993 1005.
44. Frescas D., Valenti L. Accili D. (2005) Nuclear trapping of the forkhead transcription factor FoxO1 via Sirt-dependent deacetylation promotes expression of glucogenetic genes. J. Biol. Chem. 280, 20589 20595.
45. Ganguli M., Chandra V., Kamboh M. I., Johnston J. M., Dodge H. H., Thelma B. K., Juyal R. C., Pandav R., Belle S. H. DeKosky S. T. (2000) Apolipoprotein E polymorphism and Alzheimer disease: the Indo-US Cross-National Dementia Study. Arch. Neurol. 57, 824 830.
46. Garcia-Alloza M., Borrelli L. A., Rozkalne A., Hyman B. T. Bacskai B. J. (2007) Curcumin labels amyloid pathology in vivo, disrupts existing plaques, and partially restores distorted neurites in an Alzheimer mouse model. J. Neurochem. 102, 1095 1104.
47. +-induced cytotoxicity in neuronal PC12 cells. J. Neurosci. Res. 70, 90 96.
48. Gilman S., Koller M., Black R. S. et al. (2005) Clinical effects of Abeta immunization (AN1792) in patients with AD in an interrupted trial. Neurology 64, 1553 1562.
49. Giri R. K., Rajagopal V. Kalra V. K. (2004) Curcumin, the active constituent of turmeric, inhibits amyloid peptide-induced cytochemokine gene expression and CCR5-mediated chemotaxis of THP-1 monocytes by modulating early growth response-1 transcription factor. J. Neurochem. 91, 1199 1210.
50. Gonzalez-Gross M., Marcos A. Pietrzik K. (2001) Nutrition and cognitive impairment in the elderly. Br. J. Nutr. 86, 313 321.
51. Good P. F., Perl D. P., Bierer L. M. Schmeidler J. (1992) Selective accumulation of aluminum and iron in the neurofibrillary tangles of Alzheimer's disease: a laser microprobe (LAMMA) study. Ann. Neurol. 31, 286 292.
52. Guo J. T., Yu J., Grass D., de Beer F. C. Kindy M. S. (2002) Inflammation-dependent cerebral deposition of serum amyloid a protein in a mouse model of amyloidosis. J. Neurosci. 22, 5900 5909.
53. Han M. K. (2003) Epigallocatechin gallate, a constituent of green tea, suppresses cytokine-induced pancreatic beta-cell damage. Exp. Mol. Med. 35, 136 139.
54. Han Y. S., Zheng W. H., Bastianetto S., Chabot J. G. Quirion R. (2004) Neuroprotective effects of resveratrol against beta-amyloid-induced neurotoxicity in rat hippocampal neurons: involvement of protein kinase C. Br. J. Pharmacol. 141, 997 1005.
55. Haque A. M., Hashimoto M., Katakura M., Hara Y. Shido O. (2008) Green tea catechins prevent cognitive deficits caused by Abeta1-40 in rats. J. Nutr. Biochem. 19, 619 626.
56. Hardy J. A. Higgins G. A. (1992) Alzheimer's disease: the amyloid cascade hypothesis. Science 256, 184 185.
57. Heneka M. T. O'Banion M. K. (2007) Inflammatory processes in Alzheimer's disease. J. Neuroimmunol. 184, 69 91.
58. Hensley K., Aksenova M., Carney J. M., Harris M. Butterfield D. A. (1995) Amyloid beta-peptide spin trapping. II: Evidence for decomposition of the PBN spin adduct. Neuroreport 6, 493 496.
59. Hock C., Konietzko U., Streffer J. R. et al. (2003) Antibodies against beta-amyloid slow cognitive decline in Alzheimer's disease. Neuron 38, 547 554.
60. Huffman M. A. (2003) Animal self-medication and ethno-medicine: exploration and exploitation of the medicinal properties of plants. Proc. Nutr. Soc. 62, 371 381.
61. Ishige K., Schubert D. Sagara Y. (2001) Flavonoids protect neuronal cells from oxidative stress by three distinct mechanisms. Free Radic. Biol. Med. 30, 433 446.
62. Ishrat T., Hoda M. N., Khan M. B., Yousuf S., Ahmad M., Khan M. M., Ahmad A. Islam F. (2009) Amelioration of cognitive deficits and neurodegeneration by curcumin in rat model of sporadic dementia of Alzheimer's type (SDAT). Eur. Neuropsychopharmacol. 19, 636 647.
63. Jang J. H. Surh Y. J. (2003) Protective effect of resveratrol on beta-amyloid-induced oxidative PC12 cell death. Free Radic. Biol. Med. 34, 1100 1110.
64. Janus C., Pearson J., McLaurin J. et al. (2000) A beta peptide immunization reduces behavioural impairment and plaques in a model of Alzheimer's disease. Nature 408, 979 982.
65. Jeon S. Y., Bae K., Seong Y. H. Song K. S. (2003) Green tea catechins as a BACE1 (beta-secretase) inhibitor. Bioorg. Med. Chem. Lett. 13, 3905 3908.
66. Jin F., Wu Q., Lu Y. F., Gong Q. H. Shi J. S. (2008) Neuroprotective effect of resveratrol on 6-OHDA-induced Parkinson's disease in rats. Eur. J. Pharmacol. 600, 78 82.
67. Kamboh M. I., Sanghera D. K., Ferrell R. E. DeKosky S. T. (1995) APOE*4-associated Alzheimer's disease risk is modified by alpha 1-antichymotrypsin polymorphism. Nat. Genet. 10, 486 488.
68. Kelley B. J. Knopman D. S. (2008) Alternative medicine and Alzheimer disease. Neurologist 14, 299 306.
69. Kim D. S., Park S. Y. Kim J. K. (2001) Curcuminoids from Curcuma longa L. (Zingiberaceae) that protect PC12 rat pheochromocytoma and normal human umbilical vein endothelial cells from betaA(1-42) insult. Neurosci. Lett. 303, 57061.
70. Kim D., Nguyen M. D., Dobbin M. M. et al. (2007a) SIRT1 deacetylase protects against neurodegeneration in models for Alzheimer's disease and amyotrophic lateral sclerosis. EMBO J. 26, 3169 3179.
71. Kim S. J., Jeong H. J., Lee K. M. et al. (2007b) Epigallocatechin-3- gallate suppresses NF-kappaB activation and phosphorylation of p38 MAPK and JNK in human astrocytoma U373MG cells. J. Nutr. Biochem. 18, 587 596.
72. Koh S. H., Lee S. M., Kim H. Y. et al. (2006) The effect of epigallocatechin gallate on suppressing disease progression of ALS model mice. Neurosci. Lett. 395, 103 107.
73. Kotilinek L. A., Bacskai B., Westerman M., Kawarabayashi T., Younkin L., Hyman B. T., Younkin S. Ashe K. H. (2002) Reversible memory loss in a mouse transgenic model of Alzheimer's disease. J. Neurosci. 22, 6331 6335.
74. Kumar A., Naidu P. S., Seghal N. Padi S. S. (2007) Neuroprotective effects of resveratrol against intracerebroventricular colchicine-induced cognitive impairment and oxidative stress in rats. Pharmacology 79, 17 26. (Pubitemid 46034173)
75. Larrieu S., Letenneur L., Helmer C., Dartigues J. F. Barberger-Gateau P. (2004) Nutritional factors and risk of incident dementia in the PAQUID longitudinal cohort. J. Nutr. Health Aging 8, 150 154.
76. Lee S. Y., Kim C. Y., Lee J. J., Jung J. G. Lee S. R. (2003) Effects of delayed administration of (-)-epigallocatechin gallate, a green tea polyphenol on the changes in polyamine levels and neuronal damage after transient forebrain ischemia in gerbils. Brain Res. Bull. 61, 399 406.
77. Levites Y., Weinreb O., Maor G., Youdim M. B. Mandel S. (2001) Green tea polyphenol (-)-epigallocatechin-3-gallate prevents N-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced dopaminergic neurodegeneration. J. Neurochem. 78, 1073 1082.
78. Levites Y., Amit T., Youdim M. B. Mandel S. (2002) Involvement of protein kinase C activation and cell survival/cell cycle genes in green tea polyphenol (-)-epigallocatechin 3-gallate neuroprotective action. J. Biol. Chem. 277, 30574 30580.
79. Levites Y., Amit T., Mandel S. Youdim M. B. (2003) Neuroprotection and neurorescue against Abeta toxicity and PKC-dependent release of nonamyloidogenic soluble precursor protein by green tea polyphenol (-)-epigallocatechin-3- gallate. FASEB J. 17, 952 954.
80. Li R., Huang Y. G., Fang D. Le W. D. (2004) (-)-Epigallocatechin gallate inhibits lipopolysaccharide-induced microglial activation and protects against inflammation-mediated dopaminergic neuronal injury. J. Neurosci. Res. 78, 723 731.
81. Li R., Peng N., Du F., Li X. P. Le W. D. (2006) Epigallocatechin gallate protects dopaminergic neurons against 1-methyl-4-phenyl-1,2,3,6- tetrahydropyridine-induced neurotoxicity by inhibiting microglial cell activation. Nan Fang Yi Ke Da Xue Xue Bao 26, 376 380.
82. Lim G. P., Chu T., Yang F., Beech W., Frautschy S. A. Cole G. M. (2001) The curry spice curcumin reduces oxidative damage and amyloid pathology in an Alzheimer transgenic mouse. J. Neurosci. 21, 8370 8377.
83. Lindsay J., Laurin D., Verreault R., Hebert R., Helliwell B., Hill G. B. McDowell I. (2002) Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am. J. Epidemiol. 156, 445 453.
84. Lleo A., Greenberg S. M. Growdon J. H. (2006) Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57, 513 533.
85. Lovell M. A., Robertson J. D., Teesdale W. J., Campbell J. L. Markesbery W. R. (1998) Copper, iron and zinc in Alzheimer's disease senile plaques. J. Neurol. Sci. 158, 47 52.
86. Lu K. T., Ko M. C., Chen B. Y., Huang J. C., Hsieh C. W., Lee M. C., Chiou R. Y., Wung B. S., Peng C. H. Yang Y. L. (2008) Neuroprotective effects of resveratrol on MPTP-induced neuron loss mediated by free radical scavenging. J. Agric. Food. Chem. 56, 6910 6913.
87. Maggini M., Vanacore N. Raschetti R. (2006) Cholinesterase inhibitors: drugs looking for a disease? PLoS Med. 3, e140.
88. Manach C., Mazur A. Scalbert A. (2005) Polyphenols and prevention of cardiovascular diseases. Curr. Opin. Lipidol. 16, 77 84.
89. Mandel S. A., Avramovich-Tirosh Y., Reznichenko L., Zheng H., Weinreb O., Amit T. Youdim M. B. (2005) Multifunctional activities of green tea catechins in neuroprotection. Modulation of cell survival genes, iron-dependent oxidative stress and PKC signaling pathway. Neuro-Signals 14, 46 60.
90. Mandel S., Amit T., Reznichenko L., Weinreb O. Youdim M. B. (2006) Green tea catechins as brain-permeable, natural iron chelators-antioxidants for the treatment of neurodegenerative disorders. Mol. Nutr. Food Res. 50, 229 234.
91. Marambaud P., Zhao H. Davies P. (2005) Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides. J. Biol. Chem. 280, 37377 37382.
92. van Marum R. J. (2008) Current and future therapy in Alzheimer's disease. Fundam. Clin. Pharmacol. 22, 265 274.
93. Masliah E., Hansen L., Adame A., Crews L., Bard F., Lee C., Seubert P., Games D., Kirby L. Schenk D. (2005) Abeta vaccination effects on plaque pathology in the absence of encephalitis in Alzheimer disease. Neurology 64, 129 131.
94. Matsuoka Y., Hasegawa H., Okuda S., Muraki T., Uruno T. Kubota K. (1995) Ameliorative effects of tea catechins on active oxygen-related nerve cell injuries. J. Pharmacol. Exp. Ther. 274, 602 608.
95. Mattson M. P. (2004) Pathways towards and away from Alzheimer's disease. Nature 430, 631 639.
96. Mattson M. P. Cheng A. (2006) Neurohormetic phytochemicals: low-dose toxins that induce adaptive neuronal stress responses. Trends Neurosci. 29, 632 639.
97. Mattson M. P., Son T. G. Camandola S. (2007) Viewpoint: mechanisms of action and therapeutic potential of neurohormetic phytochemicals. Dose Response 5, 174 186.
98. McCusker S. M., Curran M. D., Dynan K. B., McCullagh C. D., Urquhart D. D., Middleton D., Patterson C. C., McIlroy S. P. Passmore A. P. (2001) Association between polymorphism in regulatory region of gene encoding tumour necrosis factor alpha and risk of Alzheimer's disease and vascular dementia: a case-control study. Lancet 357, 436 439.
99. McDaniel M. A., Maier S. F. Einstein G. O. (2003) "Brain- specific" nutrients: a memory cure? Nutrition 19, 957 975.
100. McGeer P. L. McGeer E. G. (2001) Inflammation, autotoxicity and Alzheimer disease. Neurobiol. Aging 22, 799 809.
101. Moghaddam S. J., Barta P., Mirabolfathinejad S. G. et al. (2009) Curcumin inhibits COPD-like airway inflammation and lung cancer progression in mice. Carcinogenesis 30, 1949 1956.
102. Mokni M., Elkahoui S., Limam F., Amri M. Aouani E. (2007) Effect of resveratrol on antioxidant enzyme activities in the brain of healthy rat. Neurochem. Res. 32, 981 987.
103. Morgan D., Diamond D. M., Gottschall P. E. et al. (2000) A beta peptide vaccination prevents memory loss in an animal model of Alzheimer's disease. Nature 408, 982 985.
104. Motterlini R., Foresti R., Bassi R. Green C. J. (2000) Curcumin, an antioxidant and anti-inflammatory agent, induces heme oxygenase-1 and protects endothelial cells against oxidative stress. Free Radic. Biol. Med. 28, 1303 1312.
105. Nakagawa K. Miyazawa T. (1997) Absorption and distribution of tea catechin, (-)-epigallocatechin-3-gallate, in the rat. J. Nutr. Sci. Vitaminol. 43, 679 684.
106. Nanji A. A., Jokelainen K., Tipoe G. L., Rahemtulla A., Thomas P. Dannenberg A. J. (2003) Curcumin prevents alcohol-induced liver disease in rats by inhibiting the expression of NF-kappa B-dependent genes. Am. J. Physiol. Gastrointest. Liver Physiol. 284, G321 G327.
107. Nicoll J. A., Mrak R. E., Graham D. I. et al. (2000) Association of interleukin-1 gene polymorphisms with Alzheimer's disease. Ann. Neurol. 47, 365 368.
108. Nie G., Cao Y. Zhao B. (2002a) Protective effects of green tea polyphenols and their major component, (-)-epigallocatechin-3-gallate (EGCG), on 6-hydroxydopamine-induced apoptosis in PC12 cells. Redox Rep 7, 171 177.
109. Nie G., Jin C., Cao Y., Shen S. Zhao B. (2002b) Distinct effects of tea catechins on 6-hydroxydopamine-induced apoptosis in PC12 cells. Arch. Biochem. Biophys. 397, 84 90.
110. Nishinaka T., Ichijo Y., Ito M., Kimura M., Katsuyama M., Iwata K., Miura T., Terada T. Yabe-Nishimura C. (2007) Curcumin activates human glutathione S-transferase P1 expression through antioxidant response element. Toxicol. Lett. 170, 238 247.
111. Obregon D. F., Rezai-Zadeh K., Bai Y. et al. (2006) ADAM10 activation is required for green tea (-)-epigallocatechin-3-gallate-induced alpha-secretase cleavage of amyloid precursor protein. J. Biol. Chem. 281, 16419 16427.
112. Ono K., Yoshiike Y., Takashima A., Hasegawa K., Naiki H. Yamada M. (2003) Potent anti-amyloidogenic and fibril-destabilizing effects of polyphenols in vitro: implications for the prevention and therapeutics of Alzheimer's disease. J. Neurochem. 87, 172 181.
113. Ono K., Hasegawa K., Naiki H. Yamada M. (2004) Curcumin has potent anti-amyloidogenic effects for Alzheimer's beta-amyloid fibrils in vitro. J. Neurosci. Res. 75, 742 750.
114. Orgogozo J. M., Dartigues J. F., Lafont S., Letenneur L., Commenges D., Salamon R., Renaud S. Breteler M. B. (1997) Wine consumption and dementia in the elderly: a prospective community study in the Bordeaux area. Rev. Neurol. 153, 185 192.
115. Orgogozo J. M., Gilman S., Dartigues J. F. et al. (2003) Subacute meningoencephalitis in a subset of patients with AD after Abeta42 immunization. Neurology 61, 46 54.
116. Pae H. O., Jeong G. S., Jeong S. O., Kim H. S., Kim S. A., Kim Y. C., Yoo S. J., Kim H. D. Chung H. T. (2007) Roles of heme oxygenase-1 in curcumin-induced growth inhibition in rat smooth muscle cells. Exp. Mol. Med. 39, 267 277.
117. Palermo C. M., Westlake C. A. Gasiewicz T. A. (2005) Epigallocatechin gallate inhibits aryl hydrocarbon receptor gene transcription through an indirect mechanism involving binding to a 90 kDa heat shock protein. Biochemistry 44, 5041 5052.
118. Pandey N., Strider J., Nolan W. C., Yan S. X. Galvin J. E. (2008) Curcumin inhibits aggregation of alpha-synuclein. Acta Neuropathol. 115, 479 489.
119. Papassotiropoulos A., Bagli M., Jessen F., Bayer T. A., Maier W., Rao M. L. Heun R. (1999) A genetic variation of the inflammatory cytokine interleukin-6 delays the initial onset and reduces the risk for sporadic Alzheimer's disease. Ann. Neurol. 45, 666 668.
120. Paresce D. M., Ghosh R. N. Maxfield F. R. (1996) Microglial cells internalize aggregates of the Alzheimer's disease amyloid beta-protein via a scavenger receptor. Neuron 17, 553 565.
121. Parker J. A., Arango M., Abderrahmane S., Lambert E., Tourette C., Catoire H. Neri C. (2005) Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons. Nat. Genet. 37, 349 350.
122. Perry R. T., Collins J. S., Harrell L. E., Acton R. T. Go R. C. (2001) Investigation of association of 13 polymorphisms in eight genes in southeastern African American Alzheimer disease patients as compared to age-matched controls. Am. J. Med. Genet. 105, 332 342.
123. Petersen R. B., Nunomura A., Lee H. G., Casadesus G., Perry G., Smith M. A. Zhu X. (2007) Signal transduction cascades associated with oxidative stress in Alzheimer's disease. J. Alzheimers Dis. 11, 143 152.
124. Pratico D. (2008) Oxidative stress hypothesis in Alzheimer's disease: a reappraisal. Trends Pharmacol. Sci. 29, 609 615.
125. Pratico D. Sung S. (2004) Lipid peroxidation and oxidative imbalance: early functional events in Alzheimer's disease. J. Alzheimers Dis. 6, 171 175.
126. Qin L., Liu Y., Cooper C., Liu B., Wilson B. Hong J. S. (2002) Microglia enhance beta-amyloid peptide-induced toxicity in cortical and mesencephalic neurons by producing reactive oxygen species. J. Neurochem. 83, 973 983.
127. Rahman I., Biswas S. K. Kirkham P. A. (2006) Regulation of inflammation and redox signaling by dietary polyphenols. Biochem. Pharmacol. 72, 1439 1452. (Pubitemid 44666744)
128. Rajeswari A. Sabesan M. (2008) Inhibition of monoamine oxidase-B by the polyphenolic compound, curcumin and its metabolite tetrahydrocurcumin, in a model of Parkinson's disease induced by MPTP neurodegeneration in mice. Inflammopharmacology 16, 96 99.
129. Rao C. V. (2007) Regulation of COX and LOX by curcumin. Adv. Exp. Med. Biol. 595, 213 226.
130. Reddy P. H. Beal M. F. (2008) Amyloid beta, mitochondrial dysfunction and synaptic damage: implications for cognitive decline in aging and Alzheimer's disease. Trends Mol. Med. 14, 45 53.
131. Rezai-Zadeh K., Shytle D., Sun N. et al. (2005) Green tea epigallocatechin-3-gallate (EGCG) modulates amyloid precursor protein cleavage and reduces cerebral amyloidosis in Alzheimer transgenic mice. J. Neurosci. 25, 8807 8814.
132. Rezai-Zadeh K., Arendash G. W., Hou H., Fernandez F., Jensen M., Runfeldt M., Shytle R. D. Tan J. (2008) Green tea epigallocatechin-3-gallate (EGCG) reduces beta-amyloid mediated cognitive impairment and modulates tau pathology in Alzheimer transgenic mice. Brain Res. 1214, 177 187.
133. Ringman J. M., Frautschy S. A., Cole G. M., Masterman D. L. Cummings J. L. (2005) A potential role of the curry spice curcumin in Alzheimer's disease. Curr. Alzheimer Res. 2, 131 136.
134. Robb E. L., Page M. M., Wiens B. E. Stuart J. A. (2008) Molecular mechanisms of oxidative stress resistance induced by resveratrol: specific and progressive induction of MnSOD. Biochem. Biophys. Res. Commun. 367, 406 412.
135. Roberson E. D. Mucke L. (2006) 100 years and counting: prospects for defeating Alzheimer's disease. Science 314, 781 784.
136. Rogers J., Cooper N. R., Webster S. et al. (1992) Complement activation by beta-amyloid in Alzheimer disease. Proc. Natl Acad. Sci. USA 89, 10016 10020.
137. Rogers J., Kirby L. C., Hempelman S. R. et al. (1993) Clinical trial of indomethacin in Alzheimer's disease. Neurology 43, 1609 1611.
138. Sandur S. K., Ichikawa H., Pandey M. K., Kunnumakkara A. B., Sung B., Sethi G. Aggarwal B. B. (2007) Role of pro-oxidants and antioxidants in the anti-inflammatory and apoptotic effects of curcumin (diferuloylmethane). Free Radic. Biol. Med. 43, 568 580.
139. Sastre M., Dewachter I., Landreth G. E., Willson T. M., Klockgether T., van Leuven F. Heneka M. T. (2003) Nonsteroidal anti-inflammatory drugs and peroxisome proliferator-activated receptor-gamma agonists modulate immunostimulated processing of amyloid precursor protein through regulation of beta-secretase. J. Neurosci. 23, 9796 9804.
140. Savaskan E., Olivieri G., Meier F., Seifritz E., Wirz-Justice A. Muller-Spahn F. (2003) Red wine ingredient resveratrol protects from beta-amyloid neurotoxicity. Gerontology 49, 380 383.
141. Scapagnini G., Colombrita C., Amadio M., D'Agata V., Arcelli E., Sapienza M., Quattrone A. Calabrese V. (2006) Curcumin activates defensive genes and protects neurons against oxidative stress. Antioxid. Redox Signal. 8, 395 403.
142. Scharf S., Mander A., Ugoni A., Vajda F. Christophidis N. (1999) A double-blind, placebo-controlled trial of diclofenac/misoprostol in Alzheimer's disease. Neurology 53, 197 201.
143. Schenk D., Barbour R., Dunn W. et al. (1999) Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse. Nature 400, 173 177.
144. Schipper H. M. (2004) Heme oxygenase expression in human central nervous system disorders. Free Radic. Biol. Med. 37, 1995 2011.
145. Schneeberger A., Mandler M., Otawa O., Zauner W., Mattner F. Schmidt W. (2009) Development of affitope vaccines for Alzheimer's disease (AD) - from concept to clinical testing. J. Nutr. Health Aging 13, 264 267.
146. Schubert D. Chevion M. (1995) The role of iron in beta amyloid toxicity. Biochem. Biophys. Res. Commun. 216, 702 707.
147. Selkoe D. J. (1996) Amyloid beta-protein and the genetics of Alzheimer's disease. J. Biol. Chem. 271, 18295 18298.
148. Sharma M. Gupta Y. K. (2002) Chronic treatment with transresveratrol prevents intracerebroventricular streptozotocin induced cognitive impairment and oxidative stress in rats. Life Sci. 71, 2489 2498.
149. Sharma M., Briyal S. Gupta Y. K. (2005) Effect of alpha lipoic acid, melatonin and trans resveratrol on intracerebroventricular streptozotocin induced spatial memory deficit in rats. Indian J. Physiol. Pharmacol. 49, 395 402.
150. Shih C. A. Lin J. K. (1993) Inhibition of 8-hydroxydeoxyguanosine formation by curcumin in mouse fibroblast cells. Carcinogenesis 14, 709 712.
151. Shishodia S., Singh T. Chaturvedi M. M. (2007) Modulation of transcription factors by curcumin. Adv. Exp. Med. Biol. 595, 127 148.
152. Singh S. Aggarwal B. B. (1995) Activation of transcription factor NF-kappa B is suppressed by curcumin (diferuloylmethane) [corrected]. J. Biol. Chem. 270, 24995 25000.
153. Singh M., Arseneault M., Sanderson T., Murthy V. Ramassamy C. (2008) Challenges for research on polyphenols from foods in Alzheimer's disease: bioavailability, metabolism, and cellular and molecular mechanisms. J. Agric. Food Chem. 56, 4855 4873.
154. Smits H. A., Rijsmus A., van Loon J. H., Wat J. W., Verhoef J., Boven L. A. Nottet H. S. (2002) Amyloid-beta-induced chemokine production in primary human macrophages and astrocytes. J. Neuroimmunol. 127, 160 168.
155. Soleas G. J., Diamandis E. P. Goldberg D. M. (1997) Resveratrol: a molecule whose time has come? And gone? Clin. Biochem. 30, 91 113.
156. Son T. G., Camandola S. Mattson M. P. (2008) Hormetic dietary phytochemicals. Neuromol. Med. 10, 236 246.
157. Suganuma M., Okabe S., Oniyama M., Tada Y., Ito H. Fujiki H. (1998) Wide distribution of [3H](-)-epigallocatechin gallate, a cancer preventive tea polyphenol, in mouse tissue. Carcinogenesis 19, 1771 1776.
158. Tuppo E. E. Arias H. R. (2005) The role of inflammation in Alzheimer's disease. Int. J. Biochem. Cell Biol. 37, 289 305.
159. Tuteja N., Singh M. B., Misra M. K., Bhalla P. L. Tuteja R. (2001) Molecular mechanisms of DNA damage and repair: progress in plants. Crit. Rev. Biochem. Mol. Biol. 36, 337 397.
160. Van Gool W. A., Weinstein H. C., Scheltens P. Walstra G. J. (2001) Effect of hydroxychloroquine on progression of dementia in early Alzheimer's disease: an 18-month randomised, double-blind, placebo-controlled study. Lancet 358, 455 460.
161. in t' Veld B. A., Ruitenberg A., Hofman A., Launer L. J., van Duijn C. M., Stijnen T., Breteler M. M. Stricker B. H. (2001) Nonsteroidal antiinflammatory drugs and the risk of Alzheimer's disease. N. Eng. J. Med. 345, 1515 1521.
162. Virgili M. Contestabile A. (2000) Partial neuroprotection of in vivo
163. Wang Q., Xu J., Rottinghaus G. E., Simonyi A., Lubahn D., Sun G. Y. Sun A. Y. (2002) Resveratrol protects against global cerebral ischemic injury in gerbils. Brain Res. 958, 439 447.
164. Wang J., Du X. X., Jiang H. Xie J. X. (2009) Curcumin attenuates 6-hydroxydopamine-induced cytotoxicity by anti-oxidation and nuclear factor-kappaB modulation in MES23.5 cells. Biochem. Pharmacol. 78, 178 183.
165. Wei Q. Y., Chen W. F., Zhou B., Yang L. Liu Z. L. (2006) Inhibition of lipid peroxidation and protein oxidation in rat liver mitochondria by curcumin and its analogues. Biochim. Biophys. Acta 1760, 70 77.
166. Wimo A., Winblad B., Aguero-Torres H. von Strauss E. (2003) The magnitude of dementia occurrence in the world. Alzheimer Dis. Assoc. Disord. 17, 63 67.
167. Wu C. C., Hsu M. C., Hsieh C. W., Lin J. B., Lai P. H. Wung B. S. (2006) Upregulation of heme oxygenase-1 by epigallocatechin-3-gallate via the phosphatidylinositol 3-kinase/Akt and ERK pathways. Life Sci. 78, 2889 2897.
168. Xia M. Q. Hyman B. T. (1999) Chemokines/chemokine receptors in the central nervous system and Alzheimer's disease. J. Neurovirol. 5, 32 41.
169. Yan S. D., Stern D., Kane M. D., Kuo Y. M., Lampert H. C. Roher A. E. (1998) RAGE-Abeta interactions in the pathophysiology of Alzheimer's disease. Restor. Neurol. Neurosci. 12, 167 173.
170. Yang F., Lim G. P., Begum A. N. et al. (2005) Curcumin inhibits formation of amyloid beta oligomers and fibrils, binds plaques, and reduces amyloid in vivo. J. Biol. Chem. 280, 5892 5901.
171. Yasojima K., Schwab C., McGeer E. G. McGeer P. L. (1999) Up-regulated production and activation of the complement system in Alzheimer's disease brain. Am. J. Pathol. 154, 927 936.
172. Zamin L. L., Dillenburg-Pilla P., Argenta-Comiran R., Horn A. P., Simao F., Nassif M., Gerhardt D., Frozza R. L. Salbego C. (2006) Protective effect of resveratrol against oxygen-glucose deprivation in organotypic hippocampal slice cultures: involvement of PI3-K pathway. Neurobiol. Dis. 24, 170 182.
173. Zandi P. P., Anthony J. C., Hayden K. M., Mehta K., Mayer L. Breitner J. C. (2002) Reduced incidence of AD with NSAID but not H2 receptor antagonists: the Cache County Study. Neurology 59, 880 886.
174. Zbarsky V., Datla K. P., Parkar S., Rai D. K., Aruoma O. I. Dexter D. T. (2005) Neuroprotective properties of the natural phenolic antioxidants curcumin and naringenin but not quercetin and fisetin in a 6-OHDA model of Parkinson's disease. Free Radic. Res. 39, 1119 1125.
175. Zhao B. L., Li X. J., He R. G., Cheng S. J. Xin W. J. (1989) Scavenging effect of extracts of green tea and natural antioxidants on active oxygen radicals. Cell Biophys. 14, 175 185.
176. Zhuang H., Kim Y. S., Koehler R. C. Dore S. (2003) Potential mechanism by which resveratrol, a red wine constituent, protects neurons. Ann. N Y Acad. Sci. 993, 276 286.